679 related articles for article (PubMed ID: 31924750)
1. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.
Thatikonda S; Pooladanda V; Sigalapalli DK; Godugu C
Cell Death Dis; 2020 Jan; 11(1):21. PubMed ID: 31924750
[TBL] [Abstract][Full Text] [Related]
2. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation.
Thatikonda S; Pooladanda V; Godugu C
J Cell Physiol; 2020 Jun; 235(6):5270-5283. PubMed ID: 31846070
[TBL] [Abstract][Full Text] [Related]
3. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
4. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
5. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
6. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
8. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
[TBL] [Abstract][Full Text] [Related]
9. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.
Huang C; Zhong W; Ren X; Huang X; Li Z; Chen C; Jiang B; Chen Z; Jian X; Yang L; Liu X; Huang H; Shen C; Chen X; Dou X; Yu B
Cell Death Dis; 2021 Oct; 12(11):963. PubMed ID: 34667159
[TBL] [Abstract][Full Text] [Related]
10. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
12. WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17.
Ti C; Chen H; Zhou W; Bian A; Hu P; Miao Y; Shao T; Liu M; Chen Y; Yi Z
Int Immunopharmacol; 2024 Jan; 127():111344. PubMed ID: 38086269
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
14. Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB/c mice by inhibiting the MAPK signaling pathway.
Long Q; Ma T; Wang Y; Chen S; Tang S; Wang T; Zhou Y; Xu K; Wan P; Cao Y
Int Immunopharmacol; 2024 Jun; 134():112261. PubMed ID: 38761783
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-κB and VEGFR2 signaling.
Li X; Xi B; Miao Y; Ma X; Zhang J; Gao J; Wei W; Zhou H; Yang C
Int Immunopharmacol; 2021 Nov; 100():108129. PubMed ID: 34547680
[TBL] [Abstract][Full Text] [Related]
17. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
An J; Li Z; Dong Y; Ren J; Huo J
Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
[TBL] [Abstract][Full Text] [Related]
18. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
[TBL] [Abstract][Full Text] [Related]
19. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
20. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.
Sun S; Zhang X; Xu M; Zhang F; Tian F; Cui J; Xia Y; Liang C; Zhou S; Wei H; Zhao H; Wu G; Xu B; Liu X; Yang G; Wang Q; Zhang L; Gong Y; Shao C; Zou Y
Cell Death Dis; 2019 Mar; 10(4):274. PubMed ID: 30894513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]